Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hair Shedding”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableStudy completedNCT02297360
What this trial is testing

Viviscal Extra-Strength Formulation To Promote Hair Growth And Decrease Shedding In Women With Thinning Hair

Who this might be right for
Hair Thinning
Ablon Skin Institute Research Center 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06797310
What this trial is testing

Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label Study

Who this might be right for
Alopecia Areata
National Taiwan University Hospital 30
Not applicableActive Not RecruitingNCT06515496
What this trial is testing

A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.

Who this might be right for
Hair ThinningHair Shedding
Scale Media Inc 100
Not applicableStudy completedNCT04652232
What this trial is testing

Efficacy Study of Cosmetic Product Against Telogen Effluvium on Women

Who this might be right for
Telogen Effluvium
Pierre Fabre Dermo Cosmetique 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT06648850
What this trial is testing

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

Who this might be right for
Telogen EffluviumFemale Pattern Hair LossFemale Pattern Hair Loss, Androgenic Alopecia+3 more
Applied Biology, Inc. 1,120
Not applicableActive Not RecruitingNCT06920758
What this trial is testing

A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.

Who this might be right for
Thinning Hair
Ablon Skin Institute Research Center 60